General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0SHPOF
ADC Name
Alpha-c-Met/EGFR-0286 bispecific antibody drug conjugate
Synonyms
Alpha-c-Met/EGFR-0286 bispecific antibody drug conjugate (Sorrento Therapeutics)
   Click to Show/Hide
Organization
Sorrento Therapeutics, Inc.
Drug Status
Investigative
Indication
In total 1 Indication(s)
Non-small cell lung cancer
Clinical candidate
.
Antibody Name
Undisclosed
Antigen Name
Hepatocyte growth factor receptor (MET); Epidermal growth factor receptor (EGFR)
 Antigen Info 
Payload Name
Undisclosed
Linker Name
Undisclosed